Skip to content
value.today

Shine Medical Technologies, Inc.

🇺🇸 Middleton, Wisconsin, USAHealth CareFounded 2010
Total raised
$84 M
5 rounds on record
Latest round
$18 M
Apr 2019
First round on record
Dec 2010
Today
Private
No later event on record

Funding rounds

5 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Shine Medical Technologies, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Apr 2019$18 MNo. 5$10 to $50 million

Shine Medical Technologies, Inc.: Raise no. 5, Apr 2019

Investors in this round

99 investors had bought by the notice of Jun 28, 2019: 99 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$18 M of $30 M offered; $12 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Anton M. Asmuth · Executive Officer, Director
  • Gregory Richard Piefer · Executive Officer, Director
  • Harsh M. Singh · Executive Officer
  • Katrina M. Pitas · Executive Officer
  • Steve M. Miltenberger · Executive Officer
  • Brad M. Wucherpfennig · Director
  • Gordon M. Gunnlaugsson · Director
  • Gregory M. Smith · Director
  • Philip M. Halpern · Director
  • Thomas Rockwell Mackie · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Anton Asmuth, Chief Financial Officer. Newest notice filed Jun 28, 2019. Read the notice at the SEC.

equity, optionsSEC
Apr 2018$18 MNo. 4$10 to $50 million

Shine Medical Technologies, Inc.: Raise no. 4, Apr 2018

Investors in this round

122 investors had bought by the notice of Nov 29, 2018: 122 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$18 M of $25 M offered; $7 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Anton M. Asmuth · Executive Officer, Director
  • Gregory Richard Piefer · Executive Officer, Director
  • Steve M. Miltenberger · Executive Officer
  • Brad M. Wucherpfennig · Director
  • Gordon M. Gunnlaugsson · Director
  • Gregory M. Smith · Director
  • Philip M. Halpern · Director
  • Thomas Rockwell Mackie · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Anton Asmuth, Chief Financial Officer. Newest notice filed Nov 29, 2018. Read the notice at the SEC.

equity, optionsSEC
Aug 2017$7 MNo. 3$2 to $10 million

Shine Medical Technologies, Inc.: Raise no. 3, Aug 2017

Investors in this round

26 investors had bought by the notice of Sep 6, 2017: 26 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$7 M of $16 M offered; $9 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
$155,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Wisconsin

People named in the notice

  • Anton M. Asmuth · Executive Officer, Director
  • Darin Richard Janecek · Executive Officer
  • Gregory Richard Piefer · Executive Officer, Director
  • Donald M. Whelley · Director
  • Gregory M. Smith · Director
  • Philip M. Halpern · Director
  • Richard H. Leazer · Director
  • Thomas Rockwell Mackie · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Piper Jaffray & Co. (CRD 665) · broker-dealer Piper Jaffray & Co. (CRD 665) · Minneapolis, MinnesotaSold in CA, CO, FL, IL, NC, NE, NY, WI

Signed by Darin Janecek, Chief Financial Officer. Newest notice filed Sep 6, 2017. Read the notice at the SEC.

debt, optionsSEC
Oct 2013$29 MNo. 2$10 to $50 million

Shine Medical Technologies, Inc.: Raise no. 2, Oct 2013

Investors in this round

217 investors had bought by the notice of Apr 3, 2017: 217 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$29 M of $30 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
$300,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Wisconsin

People named in the notice

  • Anton M. Asmuth · Executive Officer, Director
  • Darin Richard Janecek · Executive Officer
  • Gregory Richard Piefer · Executive Officer, Director
  • James M. Costedio · Executive Officer
  • Katrina M. Pitas · Executive Officer
  • Donald M. Whelley · Director
  • Philip M. Halpern · Director
  • Richard H. Leazer · Director
  • Thomas Rockwell Mackie · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Piper Jaffray & Co. (CRD 665) · broker-dealer Piper Jaffray & Co. (CRD 665) · Minneapolis, MinnesotaSold in CA, CO, FL, IL, NC, NE, NY, WI

Signed by Darin Janecek, Chief Financial Officer. Newest notice filed Apr 3, 2017 (2 amendments). Read the notice at the SEC.

debt, optionsSEC
Dec 2010$11 MNo. 1$10 to $50 million

Shine Medical Technologies, Inc.: Raise no. 1, Dec 2010

Investors in this round

15 investors had bought by the notice of Oct 19, 2012: 15 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$11 M of $11 M offered
Smallest investment taken
no minimum stated
What was sold
equity, debt, other: Conversion of Debt to Equity and Sale of Additional Equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$256,310 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Wisconsin

People named in the notice

  • Gregory Richard Piefer · Executive Officer, Director, Promoter
  • Stephen Clermont Hathaway · Executive Officer, Promoter
  • Christopher H. Manuele · Director
  • Donald H. Whelley · Director
  • Fred H. Mancheski · Director
  • Richard Clermont Vann Bynum · Director
  • Richard H. Leazer · Director
  • Thomas Rockwell Mackie · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Gregory R. Piefer, Chief Executive Officer. Newest notice filed Oct 19, 2012 (2 amendments). Read the notice at the SEC.

equity, debtSEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Shine Medical Technologies, Inc. chose not to state its revenue in its newest notice of a funding round (Jun 2019).

    SEC Form D · Jun 2019

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Jun 2019

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Shine Medical Technologies, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Shine Medical Technologies, Inc.
NameRoleNamed in
Anton M. AsmuthExecutive officerJun 2019
Gregory Richard PieferExecutive officerJun 2019
Harsh M. SinghExecutive officerJun 2019
Katrina M. PitasExecutive officerJun 2019
Steve M. MiltenbergerExecutive officerJun 2019
Darin Richard JanecekExecutive officerSep 2017
James M. CostedioExecutive officerApr 2017
Richard Richard Vann BynumExecutive officerJan 2016
Todd M. AsmuthExecutive officerJan 2016
Stephen Clermont HathawayExecutive officerOct 2012
David A. WeissburgExecutive officerMar 2012
Anton M. AsmuthDirectorJun 2019
Brad M. WucherpfennigDirectorJun 2019
Gordon M. GunnlaugssonDirectorJun 2019
Gregory M. SmithDirectorJun 2019
Gregory Richard PieferDirectorJun 2019
Philip M. HalpernDirectorJun 2019
Thomas Rockwell MackieDirectorJun 2019
Donald M. WhelleyDirectorSep 2017
Richard H. LeazerDirectorSep 2017
Todd M. AsmuthDirectorJan 2016
Christopher H. ManueleDirectorOct 2012
Donald H. WhelleyDirectorOct 2012
Fred H. MancheskiDirectorOct 2012
Richard Clermont Vann BynumDirectorOct 2012
David A. WeissburgDirectorMar 2012
Gregory Richard PieferPromoterOct 2012
Stephen Clermont HathawayPromoterOct 2012
David A. WeissburgPromoterMar 2012